ONCY turned down RocheRoche lowball offer was declined (partnership).
What happenned was Goblet trial was so strong that ONCY is going for an open competitive process for licensing deals.
So, so, so, ONCY is saying take us over at full price or nothing. Licensing is still possible for Roche but you have to bid with the rest of them.
Take-over odds actually increased.